With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute

A resolution to Alkermes’ dispute with Johnson & Johnson may have just loomed into view. Months after J&J’s Janssen moved to partially terminate its license pact with Alkermes, the companies have begun arbitration in a bid to reach an agreement.